Post Market Clinical Follow-Up KeriFlex®
Launched by KERI MEDICAL SA · Aug 6, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating the KeriFlex® joint implant, which is designed to help patients with conditions like rheumatoid arthritis, degenerative arthritis, and traumatic arthritis. The main goal is to see how well the implant works and how safe it is over both short and long periods of time. The researchers want to make sure that the implant performs as expected and doesn’t cause any problems when used according to the instructions provided.
To be eligible for this study, participants need to be adults aged 18 or older who are planning to have surgery to replace specific finger joints using the KeriFlex® implant. However, there are some people who cannot participate, such as pregnant or breastfeeding women and those with certain health issues that could complicate the surgery. If you join this trial, you can expect to receive the KeriFlex® implant and be monitored for your progress after the surgery to help ensure it is effective and safe. This study is currently looking for volunteers, and both men and women are welcome to participate.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients (age ≥ 18 years)
- • Patients who are going to undergo arthroplasty of the metacarpophalangeal or proximal interphalangeal joint using a KeriFlex® implant in accordance with the instructions for use and the labelling in force.
- • Patients with rheumatoid arthritis, osteoarthritis or post-traumatic osteoarthritis
- Exclusion Criteria:
- • Pregnant or breastfeeding women
- • Patients with an intellectual disability who cannot follow their surgeon's instructions
- • Patients with general surgery contraindications and particularly to the implantation of a KeriFlex® implant
- • Patients with acute or chronic, local or systemic infections
- • Metacarpal or phalanx destruction or poor bone quality preventing adequate fixation
- • Muscle loss, alteration or vascular deficiency in the affected finger
- • Patients with significant physical activity involving treated joint
- • Children, young growing patients with open epiphyses
About Keri Medical Sa
Keri Medical SA is a pioneering clinical trial sponsor dedicated to advancing medical research and innovative therapies. With a focus on enhancing patient outcomes, the company specializes in the development and management of clinical trials across various therapeutic areas. Keri Medical SA leverages cutting-edge technology and a team of experienced professionals to ensure the highest standards of compliance, quality, and efficiency in trial execution. Committed to collaboration and transparency, the organization partners with healthcare providers, research institutions, and regulatory bodies to drive progress in the medical field and bring transformative solutions to market.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Besançon Cedex, , France
Lesquin Cedex, , France
Pessac, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported